<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946151</url>
  </required_header>
  <id_info>
    <org_study_id>2016IL01</org_study_id>
    <secondary_id>CIV-16-05-015704</secondary_id>
    <nct_id>NCT02946151</nct_id>
  </id_info>
  <brief_title>Subcutaneous EEG in Epilepsy</brief_title>
  <official_title>Subcutaneous EEG in Epilepsy - Proof of Concept and Clinical Applications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UNEEG Medical A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technical University of Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a two-phase study, which aims to explore the uses of a novel electrode type in&#xD;
      detecting epileptic seizures. The electrode is designed for subcutaneous implantation with&#xD;
      long-term monitoring in mind.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The problem of unrecognized seizures is common for certain types of epilepsy.&#xD;
      Electroencephalography (EEG) is an excellent method for seizure identification and&#xD;
      recognition, but until now, it has not been feasible to perform EEG recordings for more than&#xD;
      a few days outside a hospital or laboratory. A novel device has been developed, which might&#xD;
      remedy that. The device is a EEG-electrode for subcutaneous implantation connected to an&#xD;
      external data storage device.&#xD;
&#xD;
      The investigators in this study hypothesize that this device might be a useful tool for&#xD;
      ultra-long-term epilepsy monitoring. The study aims to investigate that. While the device&#xD;
      might be used to diagnose epilepsy, it is more likely to be a good seizure counting tool and&#xD;
      that is what the study aims to determine.&#xD;
&#xD;
      Subjects include patients with mesial temporal lobe epilepsy and high seizure frequency.&#xD;
      These will have the device implanted. Study phase 1 is a proof of concept to determine&#xD;
      whether the device is actually able to detect epileptic seizures. This will take place during&#xD;
      admission and be performed as simultaneous recordings with ordinary scalp EEG and the&#xD;
      investigational device. Study phase 2 is a home monitoring to prove that devices actually&#xD;
      provides clinically useful information regarding seizures in an outpatient setting.&#xD;
&#xD;
      The study requires 9 visits from each subject over the course of 4-6 months. The&#xD;
      investigational device will be explanted after approximately 75 days of wear.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">February 11, 2019</completion_date>
  <primary_completion_date type="Actual">January 23, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seizure comparison</measure>
    <time_frame>24 months</time_frame>
    <description>Qualitative comparison of patient-recorded seizures and EEGgraphical seizures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Descriptive account of device related adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compliance</measure>
    <time_frame>24 months</time_frame>
    <description>Descriptive account of compliance in use of the investigational device</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Temporal Lobe Epilepsy</condition>
  <arm_group>
    <arm_group_label>Implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of a subcutaneous electrode and connection to the external logging device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UNEEG implantable EEG electrode and data storage device</intervention_name>
    <description>The implantable EEG electrode will be implanted subcutaneously in the relevant temporal region by a certified neurosurgeon. The EEGgraphical data recorded will be transmitted transcutaneously to the data storage device via an inductive link, providing continuous data on brain activity.</description>
    <arm_group_label>Implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Semiology of some seizures compatible with mesial temporal lobe involvement.&#xD;
&#xD;
          2. Paraclinical findings supporting mesial temporal seizure focus. Such proof may consist&#xD;
             of:&#xD;
&#xD;
               -  previous EEG recording interpreted as compatible with mesial temporal involvement&#xD;
                  OR&#xD;
&#xD;
               -  radiological findings demonstrating pathology in the mesial temporal area (CT,&#xD;
                  MRI, FDG-PET or SPECT).&#xD;
&#xD;
          3. Age 18-90.&#xD;
&#xD;
          4. Current seizure frequency (fulfilling criteria 1) of more than one per week to be&#xD;
             eligible to EMU admission or 1 per month for direct enrollment to home monitoring (by&#xD;
             own account).&#xD;
&#xD;
          5. Available for the duration of the study (6 months from screening).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known disorder of hemostasis.&#xD;
&#xD;
          2. Daily or frequent (more than 2 days per week) treatment with any drugs of the&#xD;
             following types:&#xD;
&#xD;
               -  antiplatelets&#xD;
&#xD;
               -  anticoagulants&#xD;
&#xD;
               -  chemotherapeutics&#xD;
&#xD;
               -  non-steroid anti-inflammatory drugs (NSAID)&#xD;
&#xD;
               -  omega 3 fatty acids (fish oil)&#xD;
&#xD;
          3. Skeletal deformities or damage at the proposed implantation site to an extent that&#xD;
             impedes correct electrode placement.&#xD;
&#xD;
          4. Scheduled facial or cranial surgery within 6 months from enrollment.&#xD;
&#xD;
          5. Active deep brain stimulation device.&#xD;
&#xD;
          6. Presence of implanted ICD pacemaker, cochlear implant or other active implants.&#xD;
&#xD;
          7. Planned transcranial magnetic stimulation (TMS) or transcranial direct current&#xD;
             stimulation (tDCS) in the duration of the study.&#xD;
&#xD;
          8. Presence of any implanted device at the proposed site of implantation.&#xD;
&#xD;
          9. Known allergy towards any material that is part of the investigational device.&#xD;
&#xD;
         10. Females of childbearing potential who are pregnant, intend to become pregnant, or are&#xD;
             not using adequate contraceptive methods throughout the study.&#xD;
&#xD;
         11. Performing extreme sport, including scuba diving (snorkel diving is allowed),&#xD;
             parachute jumping or martial arts.&#xD;
&#xD;
         12. Scheduled MRI within 5 months from enrollment.&#xD;
&#xD;
         13. Work involving operation of MRI-scanner.&#xD;
&#xD;
         14. Operating hand held transceivers for communication (e.g. within the police, medical,&#xD;
             fire, air traffic control, marine or military).&#xD;
&#xD;
         15. Working at broadcast stations for television or FM/DAB radio.&#xD;
&#xD;
         16. Known or suspected abuse of alcohol defined as estimated consumption beyond that,&#xD;
             which is recommended by the DHA or any other neuro-active substances.&#xD;
&#xD;
         17. Active vagus nerve stimulator.&#xD;
&#xD;
         18. Skin disorders near the proposed implantation site, including infection.&#xD;
&#xD;
         19. Contraindications against the local anesthetic drug used during im- and explantation.&#xD;
&#xD;
         20. Diabetes of any kind.&#xD;
&#xD;
         21. Psychiatric disorders including:&#xD;
&#xD;
               -  schizophrenia&#xD;
&#xD;
               -  bipolar affective disorder&#xD;
&#xD;
               -  emotionally unstable personality disorder&#xD;
&#xD;
               -  schizoaffective disorder&#xD;
&#xD;
               -  schizotypal disorder&#xD;
&#xD;
               -  autism&#xD;
&#xD;
         22. Severely abnormal paraclinical findings or vital signs:&#xD;
&#xD;
               -  S-creatinine ≥ 3 times upper reference value&#xD;
&#xD;
               -  ALAT, alkaline phosphatase or bilirubin≥ 3 times upper reference value&#xD;
&#xD;
               -  APTT &gt; 50 seconds&#xD;
&#xD;
               -  thrombocyte count &lt; 50 or &gt;1000 x 10^9/l&#xD;
&#xD;
               -  INR ≥ 1,6&#xD;
&#xD;
               -  HgBA1C &gt; 55 mmol/mol&#xD;
&#xD;
               -  Any ECG finding requiring immediate referral to a cardiologist as assessed by the&#xD;
                  investigator&#xD;
&#xD;
               -  pulse &lt;40 bpm or &gt;120 bpm or suspicion of atrial fibrillation by auscultation&#xD;
&#xD;
               -  temperature &gt;38 ºC&#xD;
&#xD;
               -  respiration rate &gt;30 pr. minute&#xD;
&#xD;
               -  systolic blood pressure &lt; 80 mmHg or &gt;220 mmHg and diastolic blood pressure &lt;50&#xD;
                  mmHg or &gt;120 mmHg&#xD;
&#xD;
               -  any other clinical or paraclinical finding suggesting known or unknown illness or&#xD;
                  disorder requiring immediate treatment as assessed by the investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Troels Kjær, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zealand University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zealand University hospital</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>October 19, 2016</study_first_submitted>
  <study_first_submitted_qc>October 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>May 6, 2019</last_update_submitted>
  <last_update_submitted_qc>May 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Seizure monitoring</keyword>
  <keyword>Electroencephalography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsy, Temporal Lobe</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>July 3, 2019</submitted>
    <returned>August 14, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

